2Lemura M, Ishii M, Sugimura T, et al. Long termconsequences of regressed coronary aneurysms after Kawasakidisease: Vascu-Lar Wall morphology andfunction[J]. Heart, 2000,83(3) : 307-311.
3K-B. LaupLand, H. Dele DaVies. Epidemiology, Etio-logy and management of Kawasaki Disease. Pediatric Cardiology, 1999,20(3) :177~ 183.
4Anne H. RowLey, MD and Stanford T. Shulman, MD. ra--wasaki Syndrome. The Pediatric clinics of NorthAmerica, 199946(2):313~329.
5Witt MT, Minich LL, Bohnsack JF, et al. Kawasakidisease:more patient are being diagnosed who do not meetAmerican Heart Association criteria. Pediatrics, 1999,104(1) : 10.
6Newburg JW, Takahashi M, Beiser AS, Burns JC, Bastian J,Chung K J, et al. A Single intravenous infusion inthe treatment of acute Kawasaki syndrome[J]. N Engl Jmed, 1991,324 (23):1633~ 1639.
7ShuLman ST. Kawasaki disease and IVIG;What's going on here?Immunotherapy with instravenous immu-noglobulins[m]. San Diego:Academic Press, 1991,261~268.
8Shinohara M, Sone K, Tornomasa T. Morphologic andfunctional assessment of coronary aneurysm after Kawasakidisease by repeated dipyridmole-Loading coronaryangiography. Am J Cardio.1998,82(1):387.
9Richard E. Behrman; Robert M. Kliegman, Waldo E. Nelson, et al. Nelson textbook of inflammation, 14 the d. W.B. Saunders Company, 19921629~631.
